Glucagon-Like Peptide-1 Receptor Agonist Protects Against Diabetic Cardiomyopathy by Modulating microRNA-29b-3p/SLMAP

PURPOSE: Our aims were to investigate the pathogenesis of diabetic cardiomyopathy (DCM) and to explore the protective effect of glucagon-like peptide-1 receptor agonist (GLP-1RA) on DCM. METHODS: After 12 weeks of treatment with exenatide-loaded microspheres, a long-acting GLP-1RA, in DCM mice, card...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Ping, Ye, Zhengqin, Li, Ran, She, Dunmin, Zong, Guannan, Zhang, Liya, Xue, Ying, Zhang, Keqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019346/
https://www.ncbi.nlm.nih.gov/pubmed/36936522
http://dx.doi.org/10.2147/DDDT.S400249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019346/
https://www.ncbi.nlm.nih.gov/pubmed/36936522
http://dx.doi.org/10.2147/DDDT.S400249

Ejemplares similares